This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cytori Therapeutics Inc
CYTX : NASDAQ : Health Care
$1.41 | %
Today's Range: 1.37 - 1.41
Avg. Daily Volume: 421,400
08/29/14 - 3:59 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
CYTX CYTORI THERAPEUTICS INC 1.40 111.36 n/m 8.90 -39.36
TRGT TARGACEPT INC 2.80 94.62 n/m 0.22 -95.59
CVM CEL-SCI CORP 1.09 86.85 n/m 0.31 79.19
CRIS CURIS INC 1.65 141.91 n/m 15.42 105.90
ISR ISORAY INC 2.51 136.53 n/m 4.51 -1.83
FCSC FIBROCELL SCIENCE INC 3.02 123.39 n/m 0.22 34.96
PIP PHARMATHENE INC 2.12 119.66 n/m 14.54 -38.07
ATHX ATHERSYS INC 1.50 115.92 n/m 2.82 -55.17
VICL VICAL INC 1.25 110.76 n/m 11.64 54.70
AMBI AMBIT BIOSCIENCES CORP 5.95 107.10 n/m 20.53 8.11
STEM STEMCELLS INC 1.54 105.70 n/m 1.22 17.09
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

CYTX Ind Avg S&P 500
n/m 79.66 19.76
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs